Effect of Secukinumab on the Different GRAPPA-OMERACT Core Domains in Psoriatic Arthritis: A Pooled Analysis of 2049 Patients.

Ana Maria OrbaiIain B McInnesLaura C CoatesM Elaine HusniDafna D GladmanLaure GossecLuminita PricopOlivier ChambenoitXiangyi MengPhilip J Mease

Published in: The Journal of rheumatology (2019)

This analysis suggests that secukinumab can benefit people with PsA across the clinical phenotypic spectrum commonly encountered in this disease.

Keyphrases